The CYP26C1 gene helps control retinoic acid, a form of vitamin A that acts as a signal during early development. If it does not work well, that signal can stay too strong for too long and may affect how parts of the body form before birth, especially the head and face. The protein made by this gene helps your cells keep vitamin A signaling in balance.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate activities in the body. Some genes provide the information needed to produce proteins, which are the working parts of cells. Others mainly help direct when certain processes happen, where they happen, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also shape how you respond to food, stress, or medications. More detailed information on this topic is available in LearnHub.
Overview
CYP26C1Gene function
What if the gene works
The CYP26C1 gene helps break down retinoic acid, a signal made from vitamin A. This helps control cell growth and how tissues form, especially during early development.
Risk
What if the gene does not work
Milder to more severe variants in the CYP26C1 gene can reduce how well cells break down retinoic acid, a vitamin A related signal. This may leave retinoic acid levels higher or longer lasting and alter gene control during development.
Treatment
What does that mean for your treatment
At present, a pathogenic or loss-of-function variant in the CYP26C1 gene does not change standard treatment or drug choices in current clinical guidelines. Researchers are studying CYP26 enzymes as possible ways to adjust retinoic acid signaling, but this has not led to a CYP26C1-specific therapy or management approach.
Conditions associated with CYP26C1
Gene function
What if the gene works
Your body needs careful control of vitamin A signals so growth and tissue upkeep stay on track. The CYP26C1 gene helps by breaking down retinoic acid, an active form of vitamin A used for cell signaling. This is how the CYP26C1 gene helps control vitamin A signals across the body.
The CYP26C1 gene makes an enzyme that breaks down retinoic acid, a signal made from vitamin A. This helps your body avoid keeping that signal active longer than needed.
By clearing retinoic acid after it has done its job, this gene helps cells respond in a more measured way. This supports normal timing of cell instructions during growth and routine tissue upkeep.
Many cells need vitamin A related messages to stay within a narrow range. The CYP26C1 gene helps keep that balance, which supports orderly development before birth.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene works more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYP26C1 gene can change the shape or stability of its enzyme, so cells break down retinoic acid, an active form of vitamin A, less effectively. Across CYP26C1 gene variants, milder changes may leave some enzyme activity, while more severe variants can sharply reduce activity or stop the protein from working at all. This can shift vitamin A signaling inside cells and may change how the protein sits in cell membranes.
How variants are linked to conditions
Research on how variants in the CYP26C1 gene are linked to conditions is still developing, and the CYP26C1 gene does not yet have a broadly confirmed link to a specific health condition. Anyone with a confirmed diagnosis involving the CYP26C1 gene should rely on guidance from their doctor or genetic counselor rather than general information.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are widespread in the general population. Most do not directly affect health and simply reflect natural human variation. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CYP26C1 gene. If a change in CYP26C1 is found on genetic testing, a doctor or genetic counselor can help explain what it may mean for you or your family.
Inheritance of CYP26C1 variants
There is not yet a broadly confirmed, disease-specific inheritance pattern for the CYP26C1 gene, so the inheritance of CYP26C1 gene variants is still being clarified as research develops. CYP26C1 is located on chromosome 10, which is one of the autosomes. That means each person inherits two copies of the CYP26C1 gene, one from each parent. In general, changes in an autosomal gene can be passed to children of any sex.
What does my CYP26C1 result mean for my family?
There is not yet a broadly confirmed inheritance pattern tied to a specific well-established condition for CYP26C1, and this understanding may change as research grows. If you have a CYP26C1 result and want to know what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your exact result and family history.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for CYP26C1 variants usually uses a blood sample, saliva sample, or cheek swab. A lab reads the DNA code in the CYP26C1 gene to look for changes, then reports whether a variant is known to be linked to a health condition, is uncertain, or is not thought to affect health.
When should I consider getting a genetic test?
There is not yet a broadly established, CYP26C1-specific medical reason for genetic testing. Decisions about testing are best made with a doctor or genetic counselor based on your health, symptoms, and family history.
A genetic result is only one part of your health story
A genetic result can give useful insight, but the amount it reveals varies with the condition and the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when considered with other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results may help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. One person may break down a drug faster or more slowly than another, which can change how much of the medicine reaches the body and how long it stays active. These differences are common and can influence how well a treatment works or how sensitive someone is to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a drug works or how the body processes it. This information can support more informed, more personalized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the CYP26C1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how a medicine is working are best discussed with your doctor. CYP26C1 has been studied because it helps the body handle vitamin A–related compounds, but this has not led to routine treatment decisions.
History
The CYP26C1 gene entered the scientific literature in the early 2000s, during a period when researchers were sorting out a small family of closely related genes involved in vitamin A biology. Building on this early work, scientists recognized CYP26C1 as distinct from the better known CYP26A1 and CYP26B1 genes. Early studies mapped where the gene is active during development, which helped place it within a growing picture of how embryos are patterned. Over time, descriptions became more precise as sequencing and laboratory methods improved. Interest in the CYP26C1 gene remained mainly within developmental genetics rather than public media, so its history is more of a steady research story than a widely known cultural one. Today, it is understood through that gradual accumulation of genetic and developmental research.